# Matignon Technologies

> Matignon Technologies is a VC fund in Paris backing Medical, Biotechnology and Medical Device. See 3 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 3
- Last investment: Sep 2010
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.matignon-gestion.fr/

Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000and the Fund has a lifespan of six years.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Biotechnology | 2 | 67% |
| Medical Device | 2 | 67% |
| Wellness | 1 | 33% |
| Health Care | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| France | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Arterial Remodeling Technologies | Arterial Remodeling Technologies SA engages in developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. The company was founded in 2002 and is based in Noisy le Roi, France. | $8.5M |  | Sep 21, 2010 | http://www.art-stent.com |
| Gentis | Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. The company's patented product is DiscCell, an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc.Gentis wasfounded on 2000 and is headquartered in Wayne, Pennsylvania. | $10M | Series A | Jun 21, 2007 | http://www.gentisinc.com |
| Alveolus | Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology. | $10M | Series B | Jul 30, 2004 | http://alveolus.com/ |

3 of 3 investments shown.

## Co-investors
- [Amundi Private Equity Funds](https://shizune.co/investors/profile/amundi-private-equity-funds) — VC Fund, 1 deal together
- [Easton Capital](https://shizune.co/investors/profile/easton-capital) — VC Fund, 1 deal together
- [EGS Healthcare Capital Partners](https://shizune.co/investors/profile/egs-healthcare-capital-partners) — VC Fund, 1 deal together
- [FCA Venture Partners](https://shizune.co/investors/profile/fca-venture-partners) — VC Fund, 1 deal together
- [InnoBio Fund](https://shizune.co/investors/profile/innobio-fund) — VC Fund, 1 deal together
- [Ivy Capital](https://shizune.co/investors/profile/ivy-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Life Science Investors in France](https://shizune.co/investors/life-science-investors-france)
- [Life Science VC Funds in France](https://shizune.co/investors/life-science-vc-funds-france)

## FAQ

### What does Matignon Technologies invest in?

Matignon Technologies invests primarily in Medical, Biotechnology and Medical Device startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Matignon Technologies last invest?

The most recent investment recorded for Matignon Technologies closed in Sep 2010. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co